These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6635440)

  • 1. Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections.
    Acar JF; Goldstein FW; Duval J
    Rev Infect Dis; 1983; 5 Suppl 3():S502-6. PubMed ID: 6635440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis.
    Karchmer AW; Archer GL; Dismukes WE
    Rev Infect Dis; 1983; 5 Suppl 3():S543-8. PubMed ID: 6556711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for experimental endocarditis due to Staphylococcus epidermidis.
    Kobasa WD; Kaye KL; Shapiro T; Kaye D
    Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
    Chamovitz B; Bryant RE; Gilbert DN; Hartstein AI
    JAMA; 1985 May; 253(19):2867-8. PubMed ID: 3989962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW; Boscia JA; Kobasa WD; Kaye D
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases.
    Simon GL; Smith RH; Sande MA
    Rev Infect Dis; 1983; 5 Suppl 3():S507-8. PubMed ID: 6635441
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.
    Massanari RM; Donta ST
    Chest; 1978 Mar; 73(3):371-5. PubMed ID: 630934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD; Wexler MA; Steigbigel NH
    J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin in the treatment of serious staphylococcal infections.
    Swanberg L; Tuazon CU
    Am J Med Sci; 1984; 287(3):49-54. PubMed ID: 6563847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
    Rouse MS; Wilcox RM; Henry NK; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Kartalija M; Sande M
    J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
    Sande MA; Johnson ML
    J Infect Dis; 1975 Apr; 131(4):367-75. PubMed ID: 1117194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS; Lam K
    J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
    Faville RJ; Zaske DE; Kaplan EL; Crossley K; Sabath LD; Quie PG
    JAMA; 1978 Oct; 240(18):1963-5. PubMed ID: 249793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis.
    Gomez EO; Jafary A; Dever LL
    Microb Drug Resist; 2010 Sep; 16(3):241-4. PubMed ID: 20617926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis and Micrococcus species successfully treated with rifampicin combined with other antibiotics.
    Colebunders R; Ursi JP; Pattyn S; Snoeck J
    J Infect; 1985 Jul; 11(1):35-9. PubMed ID: 3875661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Barriere SL; Albrecht LM; Rybak MJ
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1184-7. PubMed ID: 2802547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methicillin-resistant Staphylococcus aureus.
    Morris JG; Tenney JH
    Ann Intern Med; 1983 Aug; 99(2):283-4. PubMed ID: 6881798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.